Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 4/2016

01.04.2016 | Original Article

Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer

verfasst von: Johanna Sjövall, Ulrika Bitzén, Elisabeth Kjellén, Per Nilsson, Peter Wahlberg, Eva Brun

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to determine whether PET scans after radiotherapy (RT), visually interpreted as equivocal regarding metabolic neck node response can be used to accurately categorize patients as responders or nonresponders using a Likert scale and/or maximum standardized uptake value (SUVmax). Other aims were to determine the performance of different methods for assessing post-RT PET scans (visual inspection, a Likert scale and SUVmax) and to establish whether any method is superior in predicting regional control (RC) and overall survival (OS).

Methods

In 105 patients with neck node-positive head and neck cancer, the neck node response was evaluated by FDG PET/CT 6 weeks after RT. The scans were clinically assessed by visual inspection and, for the purposes of this analysis, re-evaluated using the Deauville criteria, a five-point Likert scale previously used in lymphoma studies. In addition, SUVmax was determined.

Results

All assessment methods were able to significantly predict RC but not OS. The methods were also able to significantly predict remission of tumour after completion of RT. Of the 105 PET scans, 19 were judged as equivocal on visual inspection. The Likert scale was preferable to SUVmax for grouping patients as responders or nonresponders.

Conclusion

All methods (visual inspection, SUVmax and the Likert scale) identified responders and nonresponders and predicted RC. A Likert scale is a promising tool to reduce to a minimum the problem of PET scans judged as equivocal. Consensus regarding qualitative assessment would facilitate PET reporting in clinical practice.
Literatur
1.
Zurück zum Zitat Pellini R, Manciocco V, Turri-Zanoni M, Vidiri A, Sanguineti G, Marucci L, et al. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease. J Craniomaxillofac Surg. 2014;42(8):1834–9. doi:10.1016/j.jcms.2014.06.023.CrossRefPubMed Pellini R, Manciocco V, Turri-Zanoni M, Vidiri A, Sanguineti G, Marucci L, et al. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease. J Craniomaxillofac Surg. 2014;42(8):1834–9. doi:10.​1016/​j.​jcms.​2014.​06.​023.CrossRefPubMed
2.
Zurück zum Zitat Schouten CS, Hoekstra OS, Leemans CR, Castelijns JA, de Bree R. Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands. Eur Arch Otorhinolaryngol. 2015;272(11):3507–13. doi:10.1007/s00405-014-3389-4.CrossRefPubMed Schouten CS, Hoekstra OS, Leemans CR, Castelijns JA, de Bree R. Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands. Eur Arch Otorhinolaryngol. 2015;272(11):3507–13. doi:10.​1007/​s00405-014-3389-4.CrossRefPubMed
3.
Zurück zum Zitat Porceddu SV, Pryor DI, Burmeister E, Burmeister BH, Poulsen MG, Foote MC, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck. 2011;33(12):1675–82. doi:10.1002/hed.21655.CrossRefPubMed Porceddu SV, Pryor DI, Burmeister E, Burmeister BH, Poulsen MG, Foote MC, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck. 2011;33(12):1675–82. doi:10.​1002/​hed.​21655.CrossRefPubMed
4.
Zurück zum Zitat Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, et al. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol. 2010;21(11):2278–83. doi:10.1093/annonc/mdq226.CrossRefPubMed Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, et al. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol. 2010;21(11):2278–83. doi:10.​1093/​annonc/​mdq226.CrossRefPubMed
5.
6.
Zurück zum Zitat Kim SY, Lee SW, Nam SY, Im KC, Kim JS, Oh SJ, et al. The feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med. 2007;48(3):373–8.PubMed Kim SY, Lee SW, Nam SY, Im KC, Kim JS, Oh SJ, et al. The feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med. 2007;48(3):373–8.PubMed
7.
Zurück zum Zitat Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6(5):371–88. doi:10.1002/ana.410060502.CrossRefPubMed Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6(5):371–88. doi:10.​1002/​ana.​410060502.CrossRefPubMed
9.
Zurück zum Zitat Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S–50. doi:10.2967/jnumed.108.057307. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S–50. doi:10.​2967/​jnumed.​108.​057307.
11.
Zurück zum Zitat Roh JL, Kim JS, Kang BC, Cho KJ, Lee SW, Kim SB, et al. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. J Surg Oncol. 2014;110(7):869–75. doi:10.1002/jso.23729.CrossRefPubMed Roh JL, Kim JS, Kang BC, Cho KJ, Lee SW, Kim SB, et al. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. J Surg Oncol. 2014;110(7):869–75. doi:10.​1002/​jso.​23729.CrossRefPubMed
12.
Zurück zum Zitat Ong SC, Schoder H, Lee NY, Patel SG, Carlson D, Fury M, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med. 2008;49(4):532–40. doi:10.2967/jnumed.107.044792.CrossRefPubMed Ong SC, Schoder H, Lee NY, Patel SG, Carlson D, Fury M, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med. 2008;49(4):532–40. doi:10.​2967/​jnumed.​107.​044792.CrossRefPubMed
13.
15.
Zurück zum Zitat Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107(1):52–9. doi:10.1182/blood-2005-06-2252.CrossRefPubMed Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107(1):52–9. doi:10.​1182/​blood-2005-06-2252.CrossRefPubMed
16.
Zurück zum Zitat Sjovall J, Wahlberg P, Almquist H, Kjellen E, Brun E. A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma. Head Neck. 2015. doi:10.1002/hed.24021.PubMed Sjovall J, Wahlberg P, Almquist H, Kjellen E, Brun E. A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma. Head Neck. 2015. doi:10.​1002/​hed.​24021.PubMed
17.
Zurück zum Zitat Gallamini A, Barrington SF, Biggi A, Chauvie S, Kostakoglu L, Gregianin M, et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica. 2014;99(6):1107–13. doi:10.3324/haematol.2013.103218.PubMedCentralCrossRefPubMed Gallamini A, Barrington SF, Biggi A, Chauvie S, Kostakoglu L, Gregianin M, et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica. 2014;99(6):1107–13. doi:10.​3324/​haematol.​2013.​103218.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol. 2007;264(5):531–8. doi:10.1007/s00405-006-0225-5.CrossRefPubMed Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol. 2007;264(5):531–8. doi:10.​1007/​s00405-006-0225-5.CrossRefPubMed
20.
Zurück zum Zitat Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, et al. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys. 2015;91(3):472–9. doi:10.1016/j.ijrobp.2014.11.002.CrossRefPubMed Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, et al. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys. 2015;91(3):472–9. doi:10.​1016/​j.​ijrobp.​2014.​11.​002.CrossRefPubMed
21.
Zurück zum Zitat Barrington SF, Qian W, Somer EJ, Franceschetto A, Bagni B, Brun E, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(10):1824–33. doi:10.1007/s00259-010-1490-5.CrossRefPubMed Barrington SF, Qian W, Somer EJ, Franceschetto A, Bagni B, Brun E, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(10):1824–33. doi:10.​1007/​s00259-010-1490-5.CrossRefPubMed
22.
Zurück zum Zitat Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, et al. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med. 2009;50(12):1940–7. doi:10.2967/jnumed.109.065300.CrossRefPubMed Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, et al. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med. 2009;50(12):1940–7. doi:10.​2967/​jnumed.​109.​065300.CrossRefPubMed
23.
Zurück zum Zitat Leung AS, Rath TJ, Hughes MA, Kim S, Branstetter BF. Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma. Head Neck. 2015. doi:10.1002/hed.24112. Leung AS, Rath TJ, Hughes MA, Kim S, Branstetter BF. Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma. Head Neck. 2015. doi:10.​1002/​hed.​24112.
24.
Zurück zum Zitat Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38(11):2083–95. doi:10.1007/s00259-011-1893-y.CrossRefPubMed Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38(11):2083–95. doi:10.​1007/​s00259-011-1893-y.CrossRefPubMed
25.
Zurück zum Zitat Prestwich R, Sen M, Scarsbrook A. Qualitative 18F-FDG PET/CT response evaluation after chemotherapy or radiotherapy for head and neck squamous cell carcinoma: is there an equivocal group? J Nucl Med. 2014;55(12):2081. doi:10.2967/jnumed.114.148114.CrossRefPubMed Prestwich R, Sen M, Scarsbrook A. Qualitative 18F-FDG PET/CT response evaluation after chemotherapy or radiotherapy for head and neck squamous cell carcinoma: is there an equivocal group? J Nucl Med. 2014;55(12):2081. doi:10.​2967/​jnumed.​114.​148114.CrossRefPubMed
26.
27.
Zurück zum Zitat van der Putten L, Hoekstra OS, de Bree R, Kuik DJ, Comans EF, Langendijk JA, et al. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting. Mol Imaging Biol. 2008;10(5):294–303. doi:10.1007/s11307-008-0154-3.PubMedCentralCrossRefPubMed van der Putten L, Hoekstra OS, de Bree R, Kuik DJ, Comans EF, Langendijk JA, et al. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting. Mol Imaging Biol. 2008;10(5):294–303. doi:10.​1007/​s11307-008-0154-3.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Sjovall J, Brun E, Almquist H, Kjellen E, Wahlberg P. Radiotherapy response in head and neck cancer – evaluation of the primary tumour site. Acta Otolaryngol. 2014;134(6):646–51. doi:10.3109/00016489.2014.895038. Sjovall J, Brun E, Almquist H, Kjellen E, Wahlberg P. Radiotherapy response in head and neck cancer – evaluation of the primary tumour site. Acta Otolaryngol. 2014;134(6):646–51. doi:10.​3109/​00016489.​2014.​895038.
Metadaten
Titel
Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer
verfasst von
Johanna Sjövall
Ulrika Bitzén
Elisabeth Kjellén
Per Nilsson
Peter Wahlberg
Eva Brun
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3194-3

Weitere Artikel der Ausgabe 4/2016

European Journal of Nuclear Medicine and Molecular Imaging 4/2016 Zur Ausgabe

Society Communications

2015 Young Investigators Meeting